Cargando…
The strategic case for establishing public-private partnerships in cancer care
BACKGROUND: In 2007, the National Cancer Institute (NCI) launched the NCI Community Cancer Centers Program (NCCCP) as a public-private partnership with community hospitals with a goal of advancing cancer care and research. In order to leverage federal dollars in a time of limited resources, matching...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604611/ https://www.ncbi.nlm.nih.gov/pubmed/26462913 http://dx.doi.org/10.1186/s12961-015-0031-x |
_version_ | 1782395072790134784 |
---|---|
author | Holden, Debra J. Reiter, Kristin O’Brien, Donna Dalton, Kathleen |
author_facet | Holden, Debra J. Reiter, Kristin O’Brien, Donna Dalton, Kathleen |
author_sort | Holden, Debra J. |
collection | PubMed |
description | BACKGROUND: In 2007, the National Cancer Institute (NCI) launched the NCI Community Cancer Centers Program (NCCCP) as a public-private partnership with community hospitals with a goal of advancing cancer care and research. In order to leverage federal dollars in a time of limited resources, matching funds from each participating hospital were required. The purpose of this paper is to examine hospitals’ level of and rationale for co-investment in this partnership, and whether there is an association between hospitals’ co-investment and achievement of strategic goals. METHODS: Analysis using a comparative case study and micro-cost data was conducted as part of a comprehensive evaluation of the NCCCP pilot to determine the level of co-investment made in support of NCI’s goals. In-person or telephone interviews with key informants were conducted at 10 participating hospital and system sites during the first and final years of implementation. Micro-cost data were collected annually from each site from 2007 to 2010. Self-reported data from each awardee are presented on patient volume and physician counts, while secondary data are used to examine the local Medicare market share. RESULTS: The rationale expressed by interviewees for participation in a public-private partnership with NCI included expectations of increased market share, higher patient volumes, and enhanced opportunities for cancer physician recruitment as a result of affiliation with the NCI. On average, hospitals invested resources into the NCCCP at a level exceeding $3 for every $1 of federal funds. Six sites experienced a statistically significant change in their Medicare market share. Cancer patient volume increased by as much as one-third from Year 1 to Year 3 for eight of the sites. Nine sites reported an increase in key cancer physician recruitment. CONCLUSIONS: Demonstrated investments in cancer care and research were associated with increases in cancer patient volume and perhaps in recruitment of key cancer physicians, but not in increased Medicare market share. Although the results reflect a small sample of hospitals, findings suggest that hospital executives believe there to be a strategic case for a public-private partnership as demonstrated through the NCCCP, which leveraged federal funds to support mutual goals for advancing cancer care and research. |
format | Online Article Text |
id | pubmed-4604611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46046112015-10-15 The strategic case for establishing public-private partnerships in cancer care Holden, Debra J. Reiter, Kristin O’Brien, Donna Dalton, Kathleen Health Res Policy Syst Research BACKGROUND: In 2007, the National Cancer Institute (NCI) launched the NCI Community Cancer Centers Program (NCCCP) as a public-private partnership with community hospitals with a goal of advancing cancer care and research. In order to leverage federal dollars in a time of limited resources, matching funds from each participating hospital were required. The purpose of this paper is to examine hospitals’ level of and rationale for co-investment in this partnership, and whether there is an association between hospitals’ co-investment and achievement of strategic goals. METHODS: Analysis using a comparative case study and micro-cost data was conducted as part of a comprehensive evaluation of the NCCCP pilot to determine the level of co-investment made in support of NCI’s goals. In-person or telephone interviews with key informants were conducted at 10 participating hospital and system sites during the first and final years of implementation. Micro-cost data were collected annually from each site from 2007 to 2010. Self-reported data from each awardee are presented on patient volume and physician counts, while secondary data are used to examine the local Medicare market share. RESULTS: The rationale expressed by interviewees for participation in a public-private partnership with NCI included expectations of increased market share, higher patient volumes, and enhanced opportunities for cancer physician recruitment as a result of affiliation with the NCI. On average, hospitals invested resources into the NCCCP at a level exceeding $3 for every $1 of federal funds. Six sites experienced a statistically significant change in their Medicare market share. Cancer patient volume increased by as much as one-third from Year 1 to Year 3 for eight of the sites. Nine sites reported an increase in key cancer physician recruitment. CONCLUSIONS: Demonstrated investments in cancer care and research were associated with increases in cancer patient volume and perhaps in recruitment of key cancer physicians, but not in increased Medicare market share. Although the results reflect a small sample of hospitals, findings suggest that hospital executives believe there to be a strategic case for a public-private partnership as demonstrated through the NCCCP, which leveraged federal funds to support mutual goals for advancing cancer care and research. BioMed Central 2015-10-14 /pmc/articles/PMC4604611/ /pubmed/26462913 http://dx.doi.org/10.1186/s12961-015-0031-x Text en © Holden et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Holden, Debra J. Reiter, Kristin O’Brien, Donna Dalton, Kathleen The strategic case for establishing public-private partnerships in cancer care |
title | The strategic case for establishing public-private partnerships in cancer care |
title_full | The strategic case for establishing public-private partnerships in cancer care |
title_fullStr | The strategic case for establishing public-private partnerships in cancer care |
title_full_unstemmed | The strategic case for establishing public-private partnerships in cancer care |
title_short | The strategic case for establishing public-private partnerships in cancer care |
title_sort | strategic case for establishing public-private partnerships in cancer care |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604611/ https://www.ncbi.nlm.nih.gov/pubmed/26462913 http://dx.doi.org/10.1186/s12961-015-0031-x |
work_keys_str_mv | AT holdendebraj thestrategiccaseforestablishingpublicprivatepartnershipsincancercare AT reiterkristin thestrategiccaseforestablishingpublicprivatepartnershipsincancercare AT obriendonna thestrategiccaseforestablishingpublicprivatepartnershipsincancercare AT daltonkathleen thestrategiccaseforestablishingpublicprivatepartnershipsincancercare AT holdendebraj strategiccaseforestablishingpublicprivatepartnershipsincancercare AT reiterkristin strategiccaseforestablishingpublicprivatepartnershipsincancercare AT obriendonna strategiccaseforestablishingpublicprivatepartnershipsincancercare AT daltonkathleen strategiccaseforestablishingpublicprivatepartnershipsincancercare |